Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Mortality After Magnetic Resonance Imaging of the Brain in Patients With Cardiovascular Implantable Devices.

Padmanabhan D, Jondal ML, Hodge DO, Mehta RA, Acker NG, Dalzell CM, Kapa S, Asirvatham SJ, Cha YM, Felmlee JP, Watson RE Jr, Friedman PA.

Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005480. doi: 10.1161/CIRCEP.117.005480.

PMID:
29321191
2.

Regulatory effects of dexamethasone on NK and T cell immunity.

Chen L, Jondal M, Yakimchuk K.

Inflammopharmacology. 2017 Nov 20. doi: 10.1007/s10787-017-0418-0. [Epub ahead of print]

PMID:
29159714
3.

Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads.

Padmanabhan D, Kella DK, Mehta R, Kapa S, Deshmukh A, Mulpuru S, Jaffe AS, Felmlee JP, Jondal ML, Dalzell CM, Asirvatham SJ, Cha YM, Watson RE Jr, Friedman PA.

Heart Rhythm. 2018 Feb;15(2):228-233. doi: 10.1016/j.hrthm.2017.10.022. Epub 2017 Oct 16.

PMID:
29045806
4.

Modification of anti-tumor immunity by tolerogenic dendritic cells.

Chen L, Hasni MS, Jondal M, Yakimchuk K.

Autoimmunity. 2017 Sep;50(6):370-376. doi: 10.1080/08916934.2017.1344837. Epub 2017 Jul 4.

PMID:
28675711
5.

Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37].

Garcia C, Rosén A, Kimby E, Aguilar-Santelises M, Jondal M, Björkholm M, Holm G, Mellstedt H.

Leuk Res. 2017 Jun;57:127. doi: 10.1016/j.leukres.2017.01.029. Epub 2017 Mar 15. No abstract available.

PMID:
28314441
6.

Magnetic Resonance Imaging in Nondependent Pacemaker Patients with Pacemakers and Defibrillators with a Nearly Depleted Battery.

Okamura H, Padmanabhan D, Watson RE Jr, Dalzell C, Acker N, Jondal M, Romme AL, Cha YM, Asirvatham SJ, Felmlee JP, Friedman PA.

Pacing Clin Electrophysiol. 2017 May;40(5):476-481. doi: 10.1111/pace.13042. Epub 2017 Mar 23.

PMID:
28169434
7.

Local glucocorticoid production in the thymus.

Talaber G, Jondal M, Okret S.

Steroids. 2015 Nov;103:58-63. doi: 10.1016/j.steroids.2015.06.010. Epub 2015 Jun 20. Review.

PMID:
26102271
8.

The selective impact of transgenically expressed glucocorticoid receptor on T cells.

Yakimchuk K, Chen L, Hasni MS, Okret S, Jondal M.

Autoimmunity. 2015 Mar;48(2):117-24. doi: 10.3109/08916934.2014.959164. Epub 2014 Nov 17.

PMID:
25401790
9.

Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis.

Talabér G, Jondal M, Okret S.

Mol Cell Endocrinol. 2013 Nov 5;380(1-2):89-98. doi: 10.1016/j.mce.2013.05.007. Epub 2013 May 21. Review.

PMID:
23707789
10.

Estrogen receptor α and β in the normal immune system and in lymphoid malignancies.

Yakimchuk K, Jondal M, Okret S.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):121-9. doi: 10.1016/j.mce.2013.05.016. Epub 2013 May 23. Review.

PMID:
23707618
11.

Keratinocyte growth factor (KGF) delays the onset of collagen-induced arthritis.

Yakimchuk K, Nandakumar KS, Chen L, Holmdahl R, Okret S, Jondal M.

Autoimmunity. 2012 Nov;45(7):510-5. doi: 10.3109/08916934.2012.712169. Epub 2012 Sep 5.

PMID:
22849314
12.

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.

Yakimchuk K, Iravani M, Hasni MS, Rhönnstad P, Nilsson S, Jondal M, Okret S.

Leukemia. 2011 Jul;25(7):1103-10. doi: 10.1038/leu.2011.68. Epub 2011 Apr 19.

PMID:
21502954
13.

Thymus-derived glucocorticoids mediate androgen effects on thymocyte homeostasis.

Chen Y, Qiao S, Tuckermann J, Okret S, Jondal M.

FASEB J. 2010 Dec;24(12):5043-51. doi: 10.1096/fj.10-168724. Epub 2010 Aug 26.

14.

IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.

Mansouri MR, Sevov M, Aleskog A, Jondal M, Merup M, Sundström C, Osorio L, Rosenquist R.

Eur J Haematol. 2010 Feb 1;84(2):109-16. doi: 10.1111/j.1600-0609.2009.01369.x. Epub 2009 Nov 3.

PMID:
19889012
15.

TLR9 activation increases TAP-independent vesicular MHC class I processing in vivo.

Chen L, Jondal M.

Scand J Immunol. 2009 Nov;70(5):431-8. doi: 10.1111/j.1365-3083.2009.02315.x.

16.

Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.

Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, Roos G, Olivecrona G, Rosenquist R.

Leuk Res. 2010 Mar;34(3):301-6. doi: 10.1016/j.leukres.2009.07.032. Epub 2009 Aug 25.

PMID:
19709746
17.

Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone.

Qiao S, Okret S, Jondal M.

Endocrinology. 2009 Sep;150(9):4163-9. doi: 10.1210/en.2009-0195. Epub 2009 Apr 30.

PMID:
19406942
18.

Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC.

Chen L, Jondal M.

Mol Immunol. 2008 Nov;46(1):158-65. doi: 10.1016/j.molimm.2008.07.018. Epub 2008 Aug 23.

PMID:
18723224
19.

Age-related synthesis of glucocorticoids in thymocytes.

Qiao S, Chen L, Okret S, Jondal M.

Exp Cell Res. 2008 Oct 1;314(16):3027-35. doi: 10.1016/j.yexcr.2008.06.014. Epub 2008 Jun 28.

PMID:
18638475
20.

Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.

Chen L, Fredholm BB, Jondal M.

Mol Immunol. 2008 Apr;45(8):2247-54. doi: 10.1016/j.molimm.2007.11.016. Epub 2008 Feb 21.

PMID:
18178251
21.

Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.

Olsson A, Norberg M, Okvist A, Derkow K, Choudhury A, Tobin G, Celsing F, Osterborg A, Rosenquist R, Jondal M, Osorio LM.

Br J Cancer. 2007 Sep 17;97(6):769-77. Epub 2007 Aug 28.

22.

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

Näslund TI, Uyttenhove C, Nordström EK, Colau D, Warnier G, Jondal M, Van den Eynde BJ, Liljeström P.

J Immunol. 2007 Jun 1;178(11):6761-9.

23.

Interference with O-glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor.

Chen L, Sundbäck J, Olofsson S, Jondal M.

Int J Cancer. 2006 Sep 15;119(6):1495-500.

24.

Age-related changes in the pancreas identified by EUS: a prospective evaluation.

Rajan E, Clain JE, Levy MJ, Norton ID, Wang KK, Wiersema MJ, Vazquez-Sequeiros E, Nelson BJ, Jondal ML, Kendall RK, Harmsen WS, Zinsmeister AR.

Gastrointest Endosc. 2005 Mar;61(3):401-6.

PMID:
15758911
25.
26.

High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.

Morales AA, Olsson A, Celsing F, Osterborg A, Jondal M, Osorio LM.

Int J Cancer. 2005 Feb 20;113(5):730-7.

27.

Different roles for glucocorticoids in thymocyte homeostasis?

Jondal M, Pazirandeh A, Okret S.

Trends Immunol. 2004 Nov;25(11):595-600. Review.

PMID:
15489188
28.

Loading of the antigen-presenting protein CD1d with synthetic glycolipids.

Wallner FK, Chen L, Moliner A, Jondal M, Elofsson M.

Chembiochem. 2004 Apr 2;5(4):437-44.

PMID:
15185366
29.
30.
31.

Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes.

Pazirandeh A, Jondal M, Okret S.

Endocrinology. 2004 May;145(5):2392-401. Epub 2004 Jan 21.

PMID:
14736739
32.

Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells.

Morales AA, Olsson A, Celsing F, Osterborg A, Jondal M, Osorio LM.

Leukemia. 2004 Jan;18(1):41-7.

PMID:
14574334
33.

EUS-guided trucut biopsy for diagnosis of an esophageal stromal tumor: case report.

Yadav D, Levy MJ, Schwartz D, Jondal ML, Clain J, Wiersema MJ.

Gastrointest Endosc. 2003 Sep;58(3):457-60. No abstract available.

PMID:
14528231
34.

Evaluation of a new curved linear array echoendoscopy system for EUS.

Shamoun DK, Chak A, Levy MJ, Pfau P, Jondal ML, Wiersema MJ.

Gastrointest Endosc. 2003 Jun;57(7):937-42.

PMID:
12776050
35.

Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA.

Levy MJ, Norton ID, Wiersema MJ, Schwartz DA, Clain JE, Vazquez-Sequeiros E, Wilson WR, Zinsmeister AR, Jondal ML.

Gastrointest Endosc. 2003 May;57(6):672-8.

PMID:
12709695
36.

Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA.

Levy MJ, Jondal ML, Clain J, Wiersema MJ.

Gastrointest Endosc. 2003 Jan;57(1):101-6.

PMID:
12518144
37.

Evaluation of indeterminate bile duct strictures by intraductal US.

Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, Petersen BT, Levy MJ, Jondal ML, Wiersema MJ.

Gastrointest Endosc. 2002 Sep;56(3):372-9.

PMID:
12196775
38.

Initial experience with EUS-guided trucut needle biopsies of perigastric organs.

Wiersema MJ, Levy MJ, Harewood GC, Vazquez-Sequeiros E, Jondal ML, Wiersema LM.

Gastrointest Endosc. 2002 Aug;56(2):275-8.

PMID:
12145612
39.

A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer.

Harewood GC, Wiersema MJ, Nelson H, Maccarty RL, Olson JE, Clain JE, Ahlquist DA, Jondal ML.

Gastroenterology. 2002 Jul;123(1):24-32.

PMID:
12105829
40.

Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma.

Vazquez-Sequeiros E, Wang L, Burgart L, Harmsen W, Zinsmeister A, Allen M, Jondal M, Wiersema M.

Gastroenterology. 2002 Jun;122(7):1815-21.

PMID:
12055589
41.

Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis.

Pazirandeh A, Xue Y, Prestegaard T, Jondal M, Okret S.

FASEB J. 2002 May;16(7):727-9. Epub 2002 Mar 26.

PMID:
11923224
42.

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

Colmenero P, Chen M, Castaños-Velez E, Liljeström P, Jondal M.

Int J Cancer. 2002 Apr 1;98(4):554-60.

43.

Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.

Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM.

Leukemia. 2001 Dec;15(12):1868-77.

PMID:
11753607
44.

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

Colmenero P, Berglund P, Kambayashi T, Biberfeld P, Liljeström P, Jondal M.

Gene Ther. 2001 Sep;8(17):1307-14.

45.

Increased serum levels of soluble Fas in progressive B-CLL.

Osorio LM, Aguilar-Santelises M, De Santiago A, Hachiya T, Mellstedt H, Jondal M.

Eur J Haematol. 2001 May;66(5):342-6.

PMID:
11422415
46.

A role for glucocorticoids in the thymus?

Jondal M, Pazirandeh A, Okret S.

Trends Immunol. 2001 Apr;22(4):185-6. No abstract available.

PMID:
11349651
47.

Glucocorticoid resistance in thymocytes from mice expressing a T cell receptor transgene.

Pazirandeh A, Xue Y, Okret S, Jondal M.

Biochem Biophys Res Commun. 2000 Sep 16;276(1):189-96.

PMID:
11006105
48.

Anti-CD3 induced thymocyte apoptosis in vivo require the antibody Fc domain.

Xue Y, Castanos-Velez E, Biberfeld P, Jondal M.

Scand J Immunol. 2000 May;51(5):441-6.

49.

Cytokine expression in B-CLL in relation to disease progression and in vitro activation.

Aguilar-Santelises M, Gigliotti D, Osorio LM, Santiago AD, Mellstedt H, Jondal M.

Med Oncol. 1999 Dec;16(4):289-95.

PMID:
10618692
50.

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.

Colmenero P, Liljeström P, Jondal M.

Gene Ther. 1999 Oct;6(10):1728-33.

Supplemental Content

Loading ...
Support Center